SCHEMBL21323106

SCHEMBL21323106

N#Cc1cc(OC(F)(F)F)ccc1OCC(=O)N1CC2CN(C(=O)c3ccc4[nH]nnc4c3)CC2C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 3/20 0.47
▸ DGAT2 Q96PD7 1/20 0.47
▸ TBK1 Q9UHD2 1/20 0.38
▸ ATXN2 Q99700 9/20 0.38
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ TLR9 Q9NR96 1/20 0.34
▸ TLR8 Q9NR97 1/20 0.34
▸ TLR7 Q9NYK1 1/20 0.34
▸ KCNK3 O14649 1/20 0.34
▸ KCNK9 Q9NPC2 1/20 0.34
▸ LIPE Q05469 1/20 0.34
▸ S1PR1 P21453 1/20 0.34
▸ KDM1A O60341 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ CFTR P13569 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16963397 1.00 ENPP2 (0.47) ENPP2DGAT2TBK1ATXN2NPC1
SCHEMBL16963395 1.00 ENPP2 (0.47) ENPP2DGAT2TBK1ATXN2NPC1
SCHEMBL16962689 0.88 ENPP2 (0.49) ENPP2DGAT2ATXN2NPC1RAB9A
SCHEMBL21323239 0.88 ENPP2 (0.49) ENPP2DGAT2ATXN2TLR9TLR8
SCHEMBL16962688 0.88 ENPP2 (0.49) ENPP2DGAT2ATXN2NPC1RAB9A
SCHEMBL16963314 0.88 ENPP2 (0.49) ENPP2DGAT2ATXN2TLR9TLR8
SCHEMBL21323020 0.88 ENPP2 (0.49) ENPP2DGAT2ATXN2NPC1RAB9A
SCHEMBL16963317 0.88 ENPP2 (0.49) ENPP2DGAT2ATXN2TLR9TLR8
SCHEMBL21323007 0.87 ENPP2 (0.56) ENPP2DGAT2ATXN2LIPE
SCHEMBL16962303 0.87 ENPP2 (0.56) ENPP2DGAT2ATXN2LIPE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback